138 related articles for article (PubMed ID: 21074195)
1. Transcription factor E3 and transcription factor EB renal cell carcinomas: clinical features, biological behavior and prognostic factors.
Malouf GG; Camparo P; Molinié V; Dedet G; Oudard S; Schleiermacher G; Theodore C; Dutcher J; Billemont B; Bompas E; Guillot A; Boccon-Gibod L; Couturier J; Escudier B
J Urol; 2011 Jan; 185(1):24-9. PubMed ID: 21074195
[TBL] [Abstract][Full Text] [Related]
2. Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature.
Camparo P; Vasiliu V; Molinie V; Couturier J; Dykema KJ; Petillo D; Furge KA; Comperat EM; Lae M; Bouvier R; Boccon-Gibod L; Denoux Y; Ferlicot S; Forest E; Fromont G; Hintzy MC; Laghouati M; Sibony M; Tucker ML; Weber N; Teh BT; Vieillefond A
Am J Surg Pathol; 2008 May; 32(5):656-70. PubMed ID: 18344867
[TBL] [Abstract][Full Text] [Related]
3. Translocation carcinoma of the kidney.
Paras FA; MacLennan GT
J Urol; 2008 May; 179(5):2007. PubMed ID: 18355851
[No Abstract] [Full Text] [Related]
4. Altered transcription factor E3 expression in unclassified adult renal cell carcinoma indicates adverse pathological features and poor outcome.
Mir MC; Trilla E; de Torres IM; Panizo A; Zlotta AR; Van Rhijn B; Morote J
BJU Int; 2011 Jul; 108(2 Pt 2):E71-6. PubMed ID: 21070573
[TBL] [Abstract][Full Text] [Related]
5. Translocation renal cell carcinoma: lack of negative impact due to lymph node spread.
Geller JI; Argani P; Adeniran A; Hampton E; De Marzo A; Hicks J; Collins MH
Cancer; 2008 Apr; 112(7):1607-16. PubMed ID: 18278810
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms underlying the MiT translocation subgroup of renal cell carcinomas.
Medendorp K; van Groningen JJ; Schepens M; Vreede L; Thijssen J; Schoenmakers EF; van den Hurk WH; Geurts van Kessel A; Kuiper RP
Cytogenet Genome Res; 2007; 118(2-4):157-65. PubMed ID: 18000366
[TBL] [Abstract][Full Text] [Related]
7. Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family.
Ramphal R; Pappo A; Zielenska M; Grant R; Ngan BY
Am J Clin Pathol; 2006 Sep; 126(3):349-64. PubMed ID: 16880148
[TBL] [Abstract][Full Text] [Related]
8. Renal cell carcinoma associated with transcription factor E3 expression and Xp11.2 translocation: incidence, characteristics, and prognosis.
Klatte T; Streubel B; Wrba F; Remzi M; Krammer B; de Martino M; Waldert M; Marberger M; Susani M; Haitel A
Am J Clin Pathol; 2012 May; 137(5):761-8. PubMed ID: 22523215
[TBL] [Abstract][Full Text] [Related]
9. Translocation renal cell carcinomas: an evolving entity and a member of the microphthalmia transcription factor-associated family of tumors.
Bambury RM; Battley JE; McCarthy A; Brady C; O'Reilly S; Kelly PJ; O'Brien F; Sweeney P; Fleming S; Mayer NJ; Power DG
Clin Genitourin Cancer; 2013 Sep; 11(3):357-61. PubMed ID: 23332637
[No Abstract] [Full Text] [Related]
10. Renal translocation carcinoma with expression of TFEB: presentation of a case with distinctive histological and immunohistochemical features.
Suárez-Vilela D; Izquierdo-García F; Méndez-Álvarez JR; Miguélez-García E; Domínguez-Iglesias F
Int J Surg Pathol; 2011 Aug; 19(4):506-9. PubMed ID: 19687027
[TBL] [Abstract][Full Text] [Related]
11. [Research advances in Xp11.2 translocation renal cell carcinoma].
Huang JH; Zhou FJ
Ai Zheng; 2008 Sep; 27(9):1006-8. PubMed ID: 18799045
[TBL] [Abstract][Full Text] [Related]
12. Renal cell carcinoma with t(6;11) translocation: a patient case with a novel Alpha-TFEB fusion point.
Zhan HQ; Wang CF; Zhu XZ; Xu XL
J Clin Oncol; 2010 Dec; 28(34):e709-13. PubMed ID: 20823414
[No Abstract] [Full Text] [Related]
13. Xp11 translocation carcinoma of the kidney presenting with multilocular cystic renal cell carcinoma-like features.
Suzigan S; Drut R; Faria P; Argani P; De Marzo AM; Barbosa RN; Mello Denadai ER; Martins-Filho J; Martucci RC; Bauab T
Int J Surg Pathol; 2007 Apr; 15(2):199-203. PubMed ID: 17478783
[TBL] [Abstract][Full Text] [Related]
14. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.
Argani P; Olgac S; Tickoo SK; Goldfischer M; Moch H; Chan DY; Eble JN; Bonsib SM; Jimeno M; Lloreta J; Billis A; Hicks J; De Marzo AM; Reuter VE; Ladanyi M
Am J Surg Pathol; 2007 Aug; 31(8):1149-60. PubMed ID: 17667536
[TBL] [Abstract][Full Text] [Related]
15. Young age as favorable prognostic factor for cancer-specific survival in localized renal cell carcinoma.
Komai Y; Fujii Y; Iimura Y; Tatokoro M; Saito K; Otsuka Y; Koga F; Arisawa C; Kawakami S; Okuno T; Tsujii T; Kageyama Y; Morimoto S; Toma T; Higashi Y; Fukui I; Kihara K
Urology; 2011 Apr; 77(4):842-7. PubMed ID: 21256565
[TBL] [Abstract][Full Text] [Related]
16. The evolving story of renal translocation carcinomas.
Argani P; Ladanyi M
Am J Clin Pathol; 2006 Sep; 126(3):332-4. PubMed ID: 16880145
[No Abstract] [Full Text] [Related]
17. Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations.
Altinok G; Kattar MM; Mohamed A; Poulik J; Grignon D; Rabah R
Pediatr Dev Pathol; 2005; 8(2):168-80. PubMed ID: 15747097
[TBL] [Abstract][Full Text] [Related]
18. Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults.
Meyer PN; Clark JI; Flanigan RC; Picken MM
Am J Clin Pathol; 2007 Jul; 128(1):70-9. PubMed ID: 17580272
[TBL] [Abstract][Full Text] [Related]
19. Translocation carcinomas of the kidney.
Argani P; Ladanyi M
Clin Lab Med; 2005 Jun; 25(2):363-78. PubMed ID: 15848741
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of key cell cycle regulators in renal cell carcinoma associated with Xp11.2 translocation.
Barroca H; Castedo S; Vieira J; Teixeira M; Müller-Höcker J
Pathol Res Pract; 2009; 205(7):466-72. PubMed ID: 19246164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
